If you've searched "wegovy pill," the answer is no longer no. Semaglutide is now FDA-approved as a tablet under the Wegovy® brand, indicated as an adjunct to a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity, or adults with overweight in the presence of at least one weight-related comorbid condition.[9][6][1] The pill people spent years waiting for is on the label. What it isn't: a lighter, easier, different drug.
A lot of the internet still blurs the line between "a pill exists" and "the pill you're picturing exists." We won't do that here. Below is what the FDA labels actually say — which pills are approved, for what, and on what terms — because the differences between these products are the whole story. You can also read our overview of weight-loss shots explained for the injectable side.
Is there a Wegovy® pill?
Yes. For weight, semaglutide's Wegovy® tablet labeling sets a recommended maintenance dosage of 25 mg orally once daily.[2] That is a real, approved, fillable product — not a pipeline rumor.
But the tablet carries rules a shot doesn't. Semaglutide's Wegovy® tablet labeling for weight is strict about dosing: take it orally once daily on an empty stomach in the morning with water (up to 4 ounces), swallow it whole, and wait at least 30 minutes before eating food, drinking beverages, or taking other oral medicines.[3] A pill is more convenient than a needle only if that routine fits your actual mornings.
Pill vs shot — what the labels actually say
For weight, semaglutide's Wegovy® injection labeling directs once-weekly subcutaneous dosing in the abdomen, thigh, or upper arm, starting at 0.25 mg once weekly with a usual recommended maintenance dosage of 2.4 mg once weekly.[4] Same molecule, same brand, two different routines: one decision a week, or one decision every morning.
One thing the label is blunt about: for weight, semaglutide's Wegovy® labeling does not recommend stacking it with other semaglutide-containing products or with any other GLP-1 receptor agonist.[5] Pill plus shot is not a strategy. See semaglutide vs tirzepatide for how the molecules compare.
Do GLP-1 weight-loss pills work?
Semaglutide isn't the only GLP-1 in a tablet. Orforglipron is approved as FOUNDAYO™, a GLP-1 receptor agonist indicated as an adjunct to a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition. FOUNDAYO™'s labeling starts orforglipron at 0.8 mg once daily and steps it up no faster than every 30 days, to a maximum dosage of 17.2 mg once daily.[7]
Here's the honest part. An approval means a product carries an indication — it does not mean it will work for you, and no label promises a number on your scale. Whether any of this is appropriate is a clinical decision that belongs to a medical provider who knows your history. Individual results vary.
Is there an oral version of Ozempic®?
Yes — and it's a different lane entirely. Oral semaglutide is approved as RYBELSUS® and OZEMPIC® tablets, indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.[8]
Read that indication closely, because this is where searches go wrong: those are diabetes tablets. Same molecule as the weight-management tablet, different label, different indication, different dose — and not interchangeable with each other. "Oral Ozempic®" and "the Wegovy® pill" are not two names for one thing.
What about tirzepatide and Zepbound®?
Tirzepatide is approved as ZEPBOUND®, indicated as an adjunct to a reduced-calorie diet and increased physical activity to reduce excess body weight and maintain weight reduction long term in adults with obesity or adults with overweight in the presence of at least one weight-related comorbid condition. For weight, Zepbound®'s labeling starts tirzepatide at 2.5 mg injected subcutaneously once weekly.[10] Zepbound® has no tablet form today.
Side effects, and who it isn't for
For weight, semaglutide's Wegovy® labeling lists nausea, diarrhea, vomiting, and constipation among the most common adverse reactions (incidence of 5% or greater).[12] Swallowing it doesn't spare you that — it's the molecule, not the needle.
For weight, semaglutide's Wegovy® labeling also carries a boxed warning for risk of thyroid C-cell tumors.[13] For weight, semaglutide's Wegovy® labeling further contraindicates it in patients with a personal or family history of medullary thyroid carcinoma or with Multiple Endocrine Neoplasia syndrome type 2.[14] This is exactly why a pill is still a prescription decision and not a shopping decision.
How much does the Wegovy® pill cost?
We won't quote you a number we can't stand behind, and neither should anyone else. What you should expect from any provider: a price you can see before you commit, billed every 4 weeks, with no surprise changes. Compounded preparations are not FDA-approved.
The honest bottom line on "weight loss pills": the pill is real now — approved, labeled, fillable. It is still the same molecule with the same warnings, the same side effects, and the same requirement that a clinician decide it's right for you. If you're weighing options, start with our weight wellness overview and a conversation with a licensed clinician.